Position in LUNG
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$66,093
+$1,867 QoQ
Shares Held
50,841
+2.1% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 107 holders
Holding Since
Dec 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LUNG Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $260,568,475 across 38 Medical Devices names. LUNG ranks #34 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
1,326,951 | $56,634,268 | |
| 2 | ZBH |
Zimmer Biomet Holdings, Inc.
|
603,216 | $51,930,865 | |
| 3 | MDT |
Medtronic plc
|
325,270 | $25,445,872 | |
| 4 | DXCM |
Dexcom Inc
|
291,053 | $19,602,419 | |
| 5 | IRTC |
iRhythm Holdings, Inc.
|
152,062 | $18,087,774 | |
| 6 | EW |
Edwards Lifesciences Corp
|
188,660 | $17,066,183 | |
| 7 | PODD |
Insulet Corp
|
87,649 | $13,344,560 | |
| 8 | SYK |
Stryker Corp
|
34,612 | $10,897,242 |
All Filings in LUNG
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,093 | 50,841 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $64,226 | 49,788 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $266,731 | 120,693 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $363,024 | 224,089 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $801,996 | 309,651 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,877,427 | 278,964 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $920,045 | 135,500 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,581,732 | 190,800 | Shares | Sole | 2024-11-14 | |
| 2023-03-31 | $285,827 | 25,566 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $532,776 | 63,200 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||